These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 17120795)
1. Engineered tissues: the regulatory path from concept to market. Hellman KB Adv Exp Med Biol; 2006; 585():363-76. PubMed ID: 17120795 [No Abstract] [Full Text] [Related]
2. Current issues in the regulation of human tissue-engineering products in the European Union. Heinonen M; Oila O; Nordström K Tissue Eng; 2005; 11(11-12):1905-11. PubMed ID: 16411837 [TBL] [Abstract][Full Text] [Related]
4. Engineering human tissue and regulation: confronting biology and law to bridge the gaps. Longley D; Lawford P Med Law Int; 2001; 5(2):101-15. PubMed ID: 14696620 [TBL] [Abstract][Full Text] [Related]
5. The regulation of allogeneic human cells and tissue products as biomaterials. Yano K; Tsuyuki K; Watanabe N; Kasanuki H; Yamato M Biomaterials; 2013 Apr; 34(13):3165-73. PubMed ID: 23410682 [TBL] [Abstract][Full Text] [Related]
6. Bone tissue engineering - a field for new medicinal products? Lewandowska-Szumiel M; Wójtowicz J Curr Pharm Biotechnol; 2011 Nov; 12(11):1850-9. PubMed ID: 21902633 [TBL] [Abstract][Full Text] [Related]
7. The government's role in advancing regenerative medicine and tissue engineering - science, safety, and ethics. Smith DS Periodontol 2000; 2006; 41():16-29. PubMed ID: 16686924 [No Abstract] [Full Text] [Related]
8. The regulation of biotechnologies: four recommendations. Fox D Hastings Cent Rep; 2008; 38(2):1 p following 56. PubMed ID: 18457229 [No Abstract] [Full Text] [Related]
9. What is the greatest regulatory challenge in the translation of biomaterials to the clinic? Prestwich GD; Bhatia S; Breuer CK; Dahl SL; Mason C; McFarland R; McQuillan DJ; Sackner-Bernstein J; Schox J; Tente WE; Trounson A Sci Transl Med; 2012 Nov; 4(160):160cm14. PubMed ID: 23152323 [TBL] [Abstract][Full Text] [Related]
10. Tissue engineering as a subdivision of bioprocess engineering: reparative tissue engineering as a subspecialty of tissue engineering. Kang KA Ann N Y Acad Sci; 2002 Jun; 961():216-9. PubMed ID: 12081904 [No Abstract] [Full Text] [Related]
11. Case studies on mechanical ventilator innovations: perspectives of two clinicians. Hess D; Branson R Respir Care; 1995 Sep; 40(9):957-67. PubMed ID: 10152240 [No Abstract] [Full Text] [Related]
12. Refurbished medical equipment. Donawa ME Med Device Technol; 1998 Apr; 9(3):12-5. PubMed ID: 10179194 [TBL] [Abstract][Full Text] [Related]
13. A millstone in the uphill battle for credibility. Czap A Altern Med Rev; 2001 Feb; 6(1):3. PubMed ID: 11207452 [No Abstract] [Full Text] [Related]
14. The Lohr decision: FDA perspective and position. Porter MJ Food Drug Law J; 1997; 52(1):7-11. PubMed ID: 10346705 [No Abstract] [Full Text] [Related]
15. Protecting the consumer from getting burned: the FDA, the administrative process, and the tentative final monograph on over-the-counter sunscreens. Jones PR Am J Law Med; 1994; 20(3):317-35. PubMed ID: 7702077 [No Abstract] [Full Text] [Related]
16. Developmental biology in bioartificial tissue design: manufacturing and regulatory considerations. Lenas P Regen Med; 2018 Jan; 13(1):7-11. PubMed ID: 29369015 [No Abstract] [Full Text] [Related]
17. The problem with the double-edged solution. Czap A Altern Med Rev; 2009 Jun; 14(2):96-8. PubMed ID: 19594219 [No Abstract] [Full Text] [Related]
18. User reporting under the Safe Medical Devices Act. Arcarese JS ANNA J; 1991 Oct; 18(5):466. PubMed ID: 1953082 [No Abstract] [Full Text] [Related]
19. Legal overprotection. Friedman JH Med Health R I; 2004 Oct; 87(10):294. PubMed ID: 15559378 [No Abstract] [Full Text] [Related]
20. Animal cloning and food safety. Bren L FDA Consum; 2007; 41(2):32-5. PubMed ID: 17582865 [No Abstract] [Full Text] [Related] [Next] [New Search]